Skip to main content

Table 3 Multivariate Cox-regression analysis on metastatic OS

From: Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

 

P value

Hazard Ratio (HR)

95% CI

Triple negativity

0.011

2.03

1.17

3.51

HER2 positivity

0.027

1.86

1.07

3.22

  1. OS: overall survival, 95% CI: 95% confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us